| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8ecf20148699384261822fe637b43109 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2001-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e907c8d96874a725dc6e46f03a984220
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8880c2b2d646e3049d54973a1f011512 |
| publicationDate |
2003-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
GB-2379738-A |
| titleOfInvention |
Diagnosis of presence of invasive tumour cells |
| abstract |
Presence or absence of invasive phenotype tumour cells particularly in breast cancers is established by profiling the oligosaccharides present in tumour cell samples e.g. using HPLC or electrophoresis. The presence of "discontinuous higher molecular weight" oligosaccharides is indicative of invasive cell presence. Kits for the diagnosis are also disclosed and monoclonal antibodies specific for oligosaccharides or for a protein displaying oligosaccharides are also claimed. |
| priorityDate |
2001-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |